Wolverine Trading, LLC Biocryst Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 40,600 shares of BCRX stock, worth $286,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,600

Previous 10,609 282.69%

Holding current value

$286,636

Previous $65,000 373.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $43,815 - $72,035	10,609 New	10,609 $65,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $81,492 - $110,784	16,364 New	16,364 $98,000
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $125,650 - $187,368	15,825 New	15,825 $133,000
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $316,616 - $541,206	27,389 New	27,389 $450,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $367,318 - $507,938	-32,855 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $482,358 - $599,129	-33,945 Reduced 50.82%	32,855 $472,000
Q2 2021 Aug 06, 2021	SELL	$9.5 - $17.24 $276,469 - $501,718	-29,102 Reduced 30.35%	66,800 $1.04 Million
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $243,372 - $449,429	33,022 Added 52.52%	95,902 $958,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $88,422 - $225,909	26,238 Added 71.61%	62,880 $472,000
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $4,709 - $7,592	-1,373 Reduced 3.61%	36,642 $141,000
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $972 - $2,872	512 Added 1.37%	38,015 $189,000
Q1 2020 May 11, 2020	BUY	$1.6 - $4.11 $31,283 - $80,358	19,552 Added 108.92%	37,503 $75,000
Q4 2019 Feb 12, 2020	SELL	$1.59 - $3.45 $47,351 - $102,744	-29,781 Reduced 62.39%	17,951 $58,000
Q2 2019 Aug 20, 2019	BUY	$2.91 - $9.15 $138,900 - $436,747	47,732 New	47,732 $181,000
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $204,433 - $269,253	-27,701 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.51 - $9.6 $111,158 - $163,920	17,075 Added 160.69%	27,701 $218,000
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $58,655 - $84,901	10,626 New	10,626 $81,000
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $43,596 - $55,858	-10,480 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.1 - $5.97 $42,967 - $62,565	10,480	10,480 $55,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.31B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Biocryst Pharmaceuticals Inc Transaction History